Logo image of JEN.BR

JENSEN-GROUP NV (JEN.BR) Stock Fundamental Analysis

EBR:JEN - Euronext Brussels - BE0003858751 - Common Stock - Currency: EUR

53.4  +0.4 (+0.75%)

Fundamental Rating

6

Taking everything into account, JEN scores 6 out of 10 in our fundamental rating. JEN was compared to 108 industry peers in the Machinery industry. While JEN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. JEN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
In the past year JEN had a positive cash flow from operations.
Each year in the past 5 years JEN has been profitable.
Of the past 5 years JEN 4 years had a positive operating cash flow.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of JEN (7.97%) is better than 85.19% of its industry peers.
JEN has a Return On Equity of 14.57%. This is amongst the best in the industry. JEN outperforms 81.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.74%, JEN belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for JEN is in line with the industry average of 9.09%.
The last Return On Invested Capital (11.74%) for JEN is above the 3 year average (9.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROIC 11.74%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 9.08%, JEN belongs to the top of the industry, outperforming 84.26% of the companies in the same industry.
In the last couple of years the Profit Margin of JEN has grown nicely.
With a decent Operating Margin value of 11.20%, JEN is doing good in the industry, outperforming 77.78% of the companies in the same industry.
JEN's Operating Margin has improved in the last couple of years.
JEN has a Gross Margin of 13.64%. This is amonst the worse of the industry: JEN underperforms 90.74% of its industry peers.
In the last couple of years the Gross Margin of JEN has grown nicely.
Industry RankSector Rank
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JEN is still creating some value.
The number of shares outstanding for JEN has been reduced compared to 1 year ago.
Compared to 5 years ago, JEN has more shares outstanding
The debt/assets ratio for JEN is higher compared to a year ago.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.34 indicates that JEN is not in any danger for bankruptcy at the moment.
JEN has a better Altman-Z score (3.34) than 77.78% of its industry peers.
JEN has a debt to FCF ratio of 3.68. This is a good value and a sign of high solvency as JEN would need 3.68 years to pay back of all of its debts.
JEN's Debt to FCF ratio of 3.68 is fine compared to the rest of the industry. JEN outperforms 64.81% of its industry peers.
JEN has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
JEN has a better Debt to Equity ratio (0.08) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Altman-Z 3.34
ROIC/WACC1.62
WACC7.23%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

JEN has a Current Ratio of 1.73. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Current ratio (1.73) which is comparable to the rest of the industry.
JEN has a Quick Ratio of 1.35. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
JEN has a Quick ratio of 1.35. This is in the better half of the industry: JEN outperforms 74.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.35
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.20% over the past year.
JEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.40% yearly.
JEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.26%.
JEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.41% yearly.
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%

3.2 Future

Based on estimates for the next years, JEN will show a small growth in Earnings Per Share. The EPS will grow by 5.48% on average per year.
JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.68% yearly.
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.48%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.33, the valuation of JEN can be described as correct.
75.00% of the companies in the same industry are more expensive than JEN, based on the Price/Earnings ratio.
JEN is valuated cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
JEN is valuated reasonably with a Price/Forward Earnings ratio of 11.01.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than the industry average as 65.74% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, JEN is valued rather cheaply.
Industry RankSector Rank
PE 12.33
Fwd PE 11.01
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

JEN's Enterprise Value to EBITDA is on the same level as the industry average.
JEN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.26
EV/EBITDA 8.68
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JEN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of JEN may justify a higher PE ratio.
PEG (NY)1.99
PEG (5Y)0.75
EPS Next 2Y5.39%
EPS Next 3Y4.65%

More info and screens

3

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.30%.
Compared to an average industry Dividend Yield of 2.65, JEN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, JEN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

17.86% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP17.86%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

More info and screens

JENSEN-GROUP NV

EBR:JEN (6/19/2025, 7:00:00 PM)

53.4

+0.4 (+0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-07 2025-08-07
Inst Owners9.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap514.24M
Analysts80
Price Target54.57 (2.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP17.86%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)122.92%
PT rev (3m)7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.47%
Valuation
Industry RankSector Rank
PE 12.33
Fwd PE 11.01
P/S 1.13
P/FCF 27.26
P/OCF 16.79
P/B 1.82
P/tB 2.23
EV/EBITDA 8.68
EPS(TTM)4.33
EY8.11%
EPS(NY)4.85
Fwd EY9.08%
FCF(TTM)1.96
FCFY3.67%
OCF(TTM)3.18
OCFY5.95%
SpS47.06
BVpS29.35
TBVpS23.91
PEG (NY)1.99
PEG (5Y)0.75
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 14.57%
ROCE 15.62%
ROIC 11.74%
ROICexc 14.09%
ROICexgc 17.48%
OM 11.2%
PM (TTM) 9.08%
GM 13.64%
FCFM 4.16%
ROA(3y)6.55%
ROA(5y)5.36%
ROE(3y)12.05%
ROE(5y)10.23%
ROIC(3y)9.39%
ROIC(5y)8.21%
ROICexc(3y)11.13%
ROICexc(5y)10.46%
ROICexgc(3y)12.99%
ROICexgc(5y)12.14%
ROCE(3y)13.16%
ROCE(5y)11.32%
ROICexcg growth 3Y5.22%
ROICexcg growth 5Y2.88%
ROICexc growth 3Y5.28%
ROICexc growth 5Y0.03%
OM growth 3Y8.87%
OM growth 5Y10.05%
PM growth 3Y17.42%
PM growth 5Y13.94%
GM growth 3Y8.28%
GM growth 5Y10.4%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 3.68
Debt/EBITDA 0.37
Cap/Depr 132.29%
Cap/Sales 2.59%
Interest Coverage 28.09
Cash Conversion 51.35%
Profit Quality 45.81%
Current Ratio 1.73
Quick Ratio 1.35
Altman-Z 3.34
F-Score6
WACC7.23%
ROIC/WACC1.62
Cap/Depr(3y)117.95%
Cap/Depr(5y)108.4%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.2%
EPS 3Y32.2%
EPS 5Y16.4%
EPS Q2Q%37.94%
EPS Next Y6.19%
EPS Next 2Y5.39%
EPS Next 3Y4.65%
EPS Next 5Y5.48%
Revenue 1Y (TTM)13.26%
Revenue growth 3Y20.39%
Revenue growth 5Y6.41%
Sales Q2Q%16.76%
Revenue Next Year12.93%
Revenue Next 2Y8.38%
Revenue Next 3Y6.45%
Revenue Next 5Y3.68%
EBIT growth 1Y24.53%
EBIT growth 3Y31.06%
EBIT growth 5Y17.1%
EBIT Next Year51.02%
EBIT Next 3Y17.26%
EBIT Next 5Y13.13%
FCF growth 1Y39.35%
FCF growth 3Y-6.22%
FCF growth 5Y1.6%
OCF growth 1Y41.62%
OCF growth 3Y-2.15%
OCF growth 5Y3.17%